There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Edesa Biotech (EDSA – Research Report), Cabaletta Bio (CABA – Research Report) and Rallybio (RLYB – Research Report) with bullish sentiments.
Edesa Biotech (EDSA)
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Edesa Biotech, with a price target of $21.00. The company’s shares closed last Tuesday at $3.15, close to its 52-week low of $2.46.
According to TipRanks.com, Bernardino is a 4-star analyst with an average return of
Edesa Biotech has an analyst consensus of Moderate Buy, with a price target consensus of $21.00.
See today’s best-performing stocks on TipRanks >>
Cabaletta Bio (CABA)
In a report released today, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Cabaletta Bio, with a price target of $25.00. The company’s shares closed last Tuesday at $13.69.
According to TipRanks.com, Tsao is a 2-star analyst with an average return of
Cabaletta Bio has an analyst consensus of Strong Buy, with a price target consensus of $31.67, which is a 71.1% upside from current levels. In a report released today, William Blair also initiated coverage with a Buy rating on the stock.
Rallybio (RLYB)
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Rallybio, with a price target of $17.00. The company’s shares closed last Tuesday at $2.07, close to its 52-week low of $1.96.
According to TipRanks.com, Kapoor has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Rallybio with a $15.67 average price target, implying a 566.8% upside from current levels. In a report released yesterday, JMP Securities also reiterated a Buy rating on the stock with a $16.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on EDSA:
